ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Mankind Pharma Limited Complete list of announcements declared & dividend announcements by Mankind Pharma Limited MANKIND

Mankind Pharma Limited MANKIND listed on NSE and deals in

Announcements and dividends declared by Mankind Pharma Limited MANKIND

Mankind Pharma forays into agri-tech space, plans to invest Rs 200 crore
Mankind Pharma on Monday announced its foray into the agri-tech segment, with plans to invest up to Rs 200 crore in the first two to three years
Announcement as on 05 April 2022

Mankind Pharma forays into agri-tech space
Mankind Pharma will its foray into the agri-tech segment, with plans to invest up to Rs 200 crore in the first two to three years. The company has set up a new arm Mankind Agritech Pvt Ltd, which will offer a variety of crop care solutions to Indian farmer
Announcement as on 04 April 2022

Mankind Pharma to acquire Panacea's formulation brands for India, Nepal
Both the entities have entered into definitive agreements for the transaction involving a total consideration of Rs 1,872 crore. Panacea Biotec Pharma Ltd is a wholly-owned subsidiary of Panacea Biotec.
Announcement as on 28 February 2022

Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's
Mankind Pharma to take over manufacturing, marketing and distribution of both products in India; entire integration and transition of the brands likely to be completed by March
Announcement as on 16 February 2022

Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Laboratories
Mankind Pharma said the market for Combihale is valued at Rs 900 crore growing at 14 per cent. The acquisition of the product is expected to strengthen the company's presence in the inhalation respiratory market segment, Mankind Pharma said in a statement.
Announcement as on 16 February 2022

Announcements by Mankind Pharma Limited first page | Next page | Prev page |

MANKIND Mankind Pharma Limited current price & indicator signals

Moving Averages for Mankind Pharma Limited

  • 5Day Average: 2198.32
  • 12Day Average: 2211.73
  • 20Day Average: 2149.41
  • 50Day Average: 2146.51
  • 100Day Average: 2201.3
  • 150Day Average: 2306.51
  • 200Day Average: 2345.28

MANKIND Indicators & signals

Indicator MACD (12,26,9)

2184.28, 2161.33, 20.58
Indicator MACD is in positive zone

Indicator ADX (14)

10.05, 24.33, 29.76
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MANKIND Mankind Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Mar 2026 2138.90 2128.70 to 2205.00 -3.13% 1 times
12 Thu Mar 2026 2207.90 2184.70 to 2243.50 -1.6% 0.38 times
11 Wed Mar 2026 2243.80 2222.30 to 2256.80 0.27% 0.52 times
10 Tue Mar 2026 2237.70 2169.20 to 2249.30 3.44% 1.3 times
09 Mon Mar 2026 2163.30 2108.30 to 2170.80 -1.08% 1.03 times
06 Fri Mar 2026 2187.00 2178.10 to 2231.70 -1.77% 0.44 times
05 Thu Mar 2026 2226.40 2191.60 to 2239.80 0.87% 0.39 times
04 Wed Mar 2026 2207.20 2195.10 to 2235.00 -1.71% 0.85 times
02 Mon Mar 2026 2245.50 2161.00 to 2251.10 -0.09% 0.68 times
27 Fri Feb 2026 2247.60 2235.00 to 2275.00 -1.41% 0.99 times
26 Thu Feb 2026 2279.70 2145.90 to 2284.90 5.75% 3.44 times
25 Wed Feb 2026 2155.70 2052.80 to 2165.00 4.92% 1 times

Videos related to: MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

 

Back to top